MyAverix Finance
TO · Healthcare
Aptose Biosciences Inc (APS)
Biotechnology
Aptose Biosciences Inc (APS) is listed on TO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $6.07M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for APS
Aptose Biosciences Inc (APS) — FAQ
What is Aptose Biosciences Inc's market cap?
Aptose Biosciences Inc (APS) has a reported market cap of $6.07M (data as of 2026-05-24).
What is APS's P/E ratio?
The price-to-earnings (P/E) ratio for Aptose Biosciences Inc (APS) is 25.00 (data as of 2026-05-24).
Does Aptose Biosciences Inc pay a dividend?
Dividend yield is not available in the current snapshot for Aptose Biosciences Inc (APS). Check the MyAverix Finance app for the latest dividend data.
What sector is Aptose Biosciences Inc in?
Aptose Biosciences Inc (APS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is APS listed on?
APS is listed on TO.
What is Aptose Biosciences Inc's net margin?
Aptose Biosciences Inc (APS) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.